Mechanism and regulation of transcriptional elongation by RNA polymerase II

Current Opinion in Cell Biology

Volumn 11, Issue 3, 1999, Pages 342-346

  Reines, Daniel ^a   Conaway, Ronald C ^b   Conaway, Joan Weliky ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

DNA RECOMBINATION; DNA REPAIR; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; YEAST;

EID: 0033151808     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80047-7     Document Type: Review

References (56)

1. Yankulov K, Blau J, Purton T, Roberts S, Bentley DL: Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 1994, 77:749-759.
2. Krumm A, Hickey LB, Groudine M: Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev 1995, 9:559-572.
3. Brown SA, Weirich CS, Newton EM, Kingston RE: Transcriptional activation domains stimulate initiation and elongation at different times and via different residues. EMBO J 1998, 17:3146-3154. This paper presents evidence that some transcriptional activation domains have distinct subdomains responsible for their effects on transcription initiation and elongation. These findings provide important insight into the nature of DNA binding transactivators and how they function in the regulation of elongation by pol II.
4. Uptain SM, Kane CM, Chamberlin MJ: Basic mechanisms of transcript elongation and its regulation. Annu Rev Biochem 1997, 66:117-172.
5. Shilatifard A, Conaway JW, Conaway RC: Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II. Curr Opin Genet Dev 1997, 7:199-204.
6. Selby CP, Sancar A: Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc Natl Acad Sci USA 1997, 94:11205-11209. This paper reports the discovery that the CSB protein is a pol II elongation factor. The authors present evidence that CSB stimulates the overall rate of elongation by suppressing transient pausing by pol II.
7. Orphanides G, Leroy G, Chang CH, Luse DS, Reinberg D: FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 1998, 92:105-116. See annotation [8•].
8. Leroy G, Orphanides G, Lane WS, Reinberg D: Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science 1998, 282:1900-1904. These papers by Orphanides et al. [7•] and Leroy et al. [8•] report reconstitution with purified proteins of promoter-dependent transcription by pol II on nucleosomal templates. In addition, the authors report discovery of a novel elongation factor, FACT, required for this process.
9. Li XY, Green MR: The HIV-1 Tat cellular coactivator Tat-Sf1 is a general transcription elongation factor. Genes Dev 1998, 12:2992-2996. This paper reports the discovery that Tat-SF1, which was originally identified as a Tat binding protein, is a pol II elongation factor. The authors present evidence that Tat-SF1 stimulates the overall rate of elongation by suppressing transient pausing by pol II.
10. Sekimizu K, Kobayashi N, Mizuno D, Natori S: Purification of a factor from Ehrlich Ascites tumor cells specifically stimulating RNA polymerase II. Biochemistry 1976, 15:5064-5070.
11. Reines D: Nascent RNA cleavage by transcription elongation complexes. In Transcription: Mechanisms and Regulation. Edited by Conaway RC, Conaway JW. New York: Raven Press; 1994:263-278.
12. Archambault J, Lacroute F, Ruet A, Friesen JD: Genetic interaction between transcription elongation factor TFIIS and RNA polymerase II. Mol Cell Biol 1992, 12:4142-4152.
13. Exinger G, Lacroute F: 6-azauracil inhibition of GTP biosynthesis in Saccharomyces cerevisiae. Curr Genet 1992, 142:749-759.
14. Wu J, Awrey DE, Edwards AM, Archambault J, Friesen JD: In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS. Proc Natl Acad Sci USA 1996, 93:11552-11557.
15. Archambault J, Jansma DB, Kawasoe JH, Arndt KT, Greenblatt J, Friesen JD: Stimulation of transcription by mutations affecting conserved regions of RNA polymerase II. J Bacteriol 1998, 180:2590-2598.
16. Lennon JC, Wind M, Saunders L, Hock MB, Reines D: Mutations in RNA polymerase II and elongation factor SII severely reduce mRNA levels in Saccharomyces cerevisiae. Mol Cell Biol 1998, 18:5771-5779. This paper reports identification of specific genes whose transcription depends upon the elongation factor SII. The authors' findings set the stage for development of gene-specific assays for SII-dependent elongation in vivo and in vitro.
17. Powell W, Reines D: Mutations in the second largest subunit of RNA polymerase II cause 6-azauracil sensitivity in yeast and increased transcriptional arrest in vitro. J Biol Chem 1996, 271:6866-6873.
18. Svejstrup JQ, Li Y, Fellows J, Gnatt A, Bjorklund S, Kornberg RD: Evidence for a mediator cycle at the initiation of transcription. Proc Natl Acad Sci USA 1997, 94:6075-6078. See annotation [19•].
19. Otero G, Fellows J, Li Y, De Bizemont T, Dirac A, Gustafsson C, Erdjument-Bromage H, Tempst P, Svejstrup JQ: Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol Cell 1999. 3:125-129. These papers by Svejstrup et al. [18•] and Otero et al. [19•] report discovery and purification of elongator from yeast. Interaction of elongator with pol II is shown to be regulated by phosphorylation of the pol II CTD. In addition, the authors present genetic evidence that elongator is involved in transcription elongation and activation in vivo.
20. Fraser NW, Sehgal PB, Darnell JE: DRB-induced premature termination of late adenovirus transcription. Nature 1978. 272:590-593.
21. Chodosh LA, Fire A, Samuels M, Sharp PA: 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem 1989, 264:2250-2257.
22. Braddock M, Thorburn AM, Kingsman AJ, Kingsman SM: Blocking of tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity. Nature 1991, 350:439-441.
23. Marciniak RA, Sharp PA: HIV-1 tat protein promotes formation of more-processive elongation complexes. EMBO J 1991, 10:4189-4196.
24. Wada T, Takagi T, YAmaguchi Y, Ferdous A, Imai T, Hirose S, SUgimoto S, Yano K, Hartzog GA, Winston F et al.: DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and SptS homologs. Genes Dev 1998, 12:343-356. See annotation [27•].
25. Swanson MS, Winston F: SPT4, SPT5, and SPT6 interactions: Effects on transcription and viability in Saccharomyces cerevisiae. Genetics 1992, 132:325-336.
26. Hartzog GA, Wada T, HAnda H, Winston F: Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev 1998, 12:357-369. See annotation [27•].
27. Wada T, Takagi T, YAmaguchi Y, Watanabe D, HAnda H: Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J 1998, 17:7395-7403. Together, the papers by Wada et al. [24•,27•] and Hartzog et al. [26•] provide genetic and biochemical evidence that DSIF (Spt4-Spt5), the DRB-sensitivity inducing factor, is a negative regulator of elongation by pol II. In addition, Wada et al. [27•] demonstrate that the positive elongation factor P-TEFb functions at least in part by counteracting the activity of DSIF.
28. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall NF, Marshall T, Amendt B, Mathews MB, Price DH: Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev 1997, 11:2622-2632. See annotation [37•].
29. Peng J, Zhu Y, Milto JT, Price DH: Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 1998, 12:755-762.
30. Peng J, Marshall NF, Price DH: Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J Biol Chem 1998, 273:13855-13860.
31. Marshall NF, Peng J, Xie Z, Price DH: Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem 1996, 271:27176-27183.
32. Zhou Q, Chen D, Pierstorff E, Luo K: Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J 1998, 17:3681-3691.
33. Chun RF, Jeang KT: Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J Biol Chem 1996, 271:27888-27894.
34. Parada CA, Roeder RG: Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 1996, 384:375-378.
35. Yang X, Herrman CH, Rice AP: The human immunodeficiency virus tat proteins specifically associate with TAK in vivo and require the carboxy-terminal domain of RNA polymerase II for function. J Virol 1996, 70:4576-4584.
36. Gold MO, Yang X, Herrmann CH, Rice AP: PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus transactivation in vivo. J Virol 1998, 72:4448-4453.
37. Mancebo HSY, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Price DH, Flores O: P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 1997, 11:2633-2644. These papers by Zhu et al. [28•] and Mancebo et al. [37•] elegantly demonstrate that the pol II CTD kinase P-TEFb plays an essential role in Tat-dependent activation of the HIV-1 mRNA synthesis. This work provides the first direct evidence that P-TEFb regulates expression of specific genes in vivo.
38. Wei P, Garber ME, Fang S, Fischer WH, Jones KA: A novel CDK9 associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462. See annotation [39•].
39. Fujinaga K, Taube R, Wimmer J, Cujec TP, Peterlin BM: Interactions between human cyclin T, Tat and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci USA 1999, 96:1285-1290. These papers by Wei et al. [38•] and Fujinaga et al. [39•] demonstrate that human, but not mouse, cyclin T interacts with the HIV-1 Tat protein and mediates its binding to the TAR element in the HIV-1 polyprotein transcript. This finding provides a mechanistic explanation for the long-standing observation that the HIV-1 is capable of infecting human but not rodent cells.
40. Friedberg EC: Relationships between DNA repair and transcription. Annu Rev Biochem 1996, 65:15-42.
41. Storb U, Peters A, Klotz E, Kim N, Shen HM, Hackett J, Rogerson B, O'Brien R, Martin TE: Immunoglobulin transgenes as targets for somatic mutation. Int J Dev Biol 1998, 42:977-982.
42. Wilson PC, Capra JD: The insertion/deletion phenotype in somatic hypermutation and a new model for somatic hypermutation. The Immunologist 1998, 6:48-53.
43. Keil RL, Roeder GS: Cis-acting, recombination-stimulating activity in fragment of the ribosomal DNA of S. cerevisiae. Cell 1984, 39:377-386.
44. Thomas BJ, Rothstein R: Elevated recombination rates in transcriptionally active DNA. Cell 1989, 56:619-630.
45. Chavez S, Aguilera A: The yeast HPR1 gene has a functional role in transcriptional elongation that uncovers a novel source of genome instability. Genes Dev 1997, 11:3459-3470. See annotation [53•].
46. Van Gool AJ, Verhage R, Swagemakers SMA, Van De Putte P, Brouwer J, Troelstra C, Bootsma D, Hoeijmakers JHJ: RAD26, the functional S. cerevisiae homolog of the cockayne syndrome B gene ERCC6. EMBO J 1994, 13:5361-5369.
47. Tantin D, Kansal A, Carey M: Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol Cell Biol 1997, 17:6803-6814.
48. Aguilera A, Klein HL: HPR1, a novel yeast gene that prevents intrachromosomal excision recombination, shows carboxy-terminal homology to the Saccharomyces cerevisiae TOP1 gene. Mol Cell Biol 1990, 10:1439-1451.
49. Santos-Rosa H, Aguilera A: Increase in incidence of chromosome instability and non-conservative recombination between repeats in Saccharomyces cerevisiae hpr1 delta strains. Mol Gen Genet 1994, 245:224-236.
50. Piruat JI, Aguilera A: A novel yeast gene, THO2, is involved in RNA pol II transcription and provides new evidence for transcriptional elongation-associated recombination. EMBO J 1998, 17:4859-4872. See annotation [53•].
51. Fan HY, Cheng KK, Klein KL: Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of Saccharomyces cerevisiae. Genetics 1996, 142:749-759.
52. Chang M, French-Cornay D, Fan H, Klein H, Denis C, Jaehning JA: A complex containing RNA polymerase II, paf1p, cdc73p, hpr1p, and ccr4p plays a role in protein kinase C signalling. Mol Cell Biol 1999, 19:1056-1067.
53. Prado F, Piruat JI, Aguilera A: Recombination between DNA repeats in yeast hpr1δ cells is linked to transcription elongation. EMBO J 1997, 16:2826-2835. Together, these papers by Chavez and Aguilera [45•], Piruat and Aguilera [50•], and Prado et al. [53•] make a strong case for a mechanistic connection between elongation by pol II, recombination, and maintenance of genome stability. In addition, the authors findings implicate the HPR1 and THO2 gene products in control of transcription elongation in cells.
54. Workman JL, Kingston RE: Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 1998, 67:545-579.
55. Brown SA, Kingston RE: Disruption of downstream chromatin directed by a transcriptional activator. Genes Dev 1997. 11:3116-3121.
56. Brown SA, Imbalzano AN, Kingston RE: Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev 1996, 10:1479-1490.